| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |